We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8331:TSEChiba Bank, Ltd. Analysis

Data as of 2026-03-14 - not real-time

HK$0.32

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical snapshot: The 20‑day SMA (0.345) sits above the 50‑day SMA (0.332) and the 200‑day SMA (0.216), suggesting a longer‑term bullish bias, yet the current price (HK$0.32) trades below all three averages. Momentum indicators are mixed – RSI is deep in oversold territory at 29.8, while the MACD histogram is negative and the signal line is bearish, implying short‑term downside pressure. The stock is hugging its immediate support at HK$0.32 and faces resistance near HK$0.35, with a recent 30‑day volatility of 42.5% and a negative beta of –0.35, indicating heightened price swings and a tendency to move opposite the market.
Fundamental backdrop: Valuation appears cheap, with a price‑to‑book of 0.42 and a price‑to‑sales near 1, but earnings are negative (trailing EPS –0.06) and margins are deeply in the red (gross 45.1%, operating –22.4%). Cash on hand (HK$15.1 M) barely offsets modest debt (HK$0.8 M) and a debt‑to‑equity of 0.75, while ROE and ROA are negative. Liquidity is thin – volume is decreasing and average daily volume is low – and the market sentiment index reads “Greed” at 72.8, hinting at speculative interest despite the weak fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with oversold RSI
  • Bearish MACD signal
  • Thin trading volume increasing liquidity risk

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent negative earnings and margins
  • High volatility and wide drawdown potential
  • Lack of dividend or earnings growth outlook

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Fundamental weakness in profitability and cash conversion
  • Elevated sector and geographic risks in Chinese mining
  • Unfavorable valuation despite low price multiples

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin-17.27%
ROE-7.89%
ROA-4.47%
Debt/Equity0.74
P/B Ratio0.4

Technical Analysis

TrendBullish
RSI29.8
SupportHK$0.32
ResistanceHK$0.35
MA 20HK$0.35
MA 50HK$0.33
MA 200HK$0.22
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.35
Volatility42.53%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.